PVI, PeerView Institute for Medical Education’s Post

Phase 1 clinical trials in oncology are essential to the natural progression of any clinical compound or device, but remain some of the most unique and challenging trials that a research site can embark on. This document outlines several of the major considerations that a site should explore when considering Phase 1 oncology trials. Many of these aspects are also applicable to other therapeutic areas, but most pertain to oncology trials. Access it here ⇢ https://lnkd.in/gBqrX2TX

Attention Drug Access Navigators: Have you used the Haven Oncology program? You and your patients can access Haven directly from our website now! Haven is a consolidated Patient Support Program with cancer drugs from multiple manufacturers. Less paperwork, streamlined communication and more to help during your day. #patientsupportprogram #oncology #drugaccess #financialassistance #cancer #patientprogram #psp

Phase 1 oncology trials are essential to the progression of any clinical compound or device, but are often some of the most challenging trials for sites. This document outlines several considerations that sites should explore when considering Phase 1 oncology trials. Access it here ⇢ https://lnkd.in/ewCisQRQ

Todays the day! Across Australia, Enhertu is now part of the Pharmaceutical Benefits Scheme for people living with HER2-low metastatic breast cancer! What a way to wind up an exciting week. If you think you're eligible for Enhertu, call your GP to discuss your options. #BCNAPinkLady #medicationcoverage #pharmaceuticalbenefitsscheme #breastcancer #metastaticbreastcancer #livingwithmbc #mbcadvocacy

Phase 1 oncology trials are essential to the progression of any clinical compound or device, but are often some of the most challenging trials for sites. This document outlines several considerations that sites should explore when considering Phase 1 oncology trials. Access it here ⇢ https://lnkd.in/dbqXRkuu

Oncology never ceases to be top of mind for our clients. This paper provides a primer on valuation issues related to oncology services. https://lnkd.in/e_85k5mh

FDA approves pembrolizumab with chemoradiotherapy for FIGO 2014 Stage III-IVA cervical cancer . . On January 12, 2024, the Food and Drug Administration approved pembrolizumab (Keytruda, Merck) with chemoradiotherapy (CRT) for patients with FIGO 2014 Stage III-IVA cervical cancer. #fda #fdaapproval #fdacompliance #fdaregulations #regulatoryaffairs #regulation #regulatorycompliance #cervicalcancer

This month, WMW acknowledges Breast Cancer Awareness Month, and the millions of people affected by this disease each year. At WMW, we provide medical communications support to pharmaceutical companies working on solutions to beat this debilitating disease. To learn more about our team’s expertise in oncology, please visit www.wiesenmed.com #breastcancer #cancerawareness #oncology #medicalwriting #medicalcommunications #medicalaffairs

Does the heterogeneity of early phase oncology studies preclude it from the need for patient reported outcomes (PROs)? The Oncology Dosing Toolkit by the FDA (as part of project OPTIMUS) does not seem to think so! But wat does "As Applicable" mean exactly?

Summary of 10 new indications/approvals in Heme Malignancies by FDA Oncology in 2023 - Oncology Brothers #Cancer #FDAOncology #HemeMalignancies #OncoDaily #Oncology #OncologyBrothers